Answers are grounded in this paper and cite their sources.
In this issue, we address the cause of the primary clinical manifestation, which is cognitive dysfunction in the elderly. As is well known, cognitive decline remains very underdiagnosed. It appears that machine learning-based EEG testing may offer a non-invasive, low-cost approach to identifying cognitive decline. In studies conducted using EEG in 60 elderly people in various cognitive states (MMSE scale) and 22 healthy people from the control group, it was shown that MMSE results significantly correlated with reaction time and EEG A0 and ST4 features. In addition, EEG features showed increased Theta, Delta, A0, and VC9 activity only in young participants, indicating a different pattern of activity between young and older participants in different cognitive states. Future studies should explore the potential usefulness of this tool to characterize cognitive changes on a large scale in a clinical setting to enable early diagnosis of cognitive decline and features of dementia.It is known that aging-related cognitive decline is related to brain structural changes and loss of synapses (Dorszewska, 2013), but may simultaneously be gender-specific. In this issue, we describe using a model from GTEx transcriptomic data from 13 brain regions of gene co-expression networks and aging-related modules and key regulators common to both sexes and specific to men and women. We indicate that the hippocampus and hypothalamus are is more sensitive in males, while the cerebellar hemisphere and anterior cingulate cortex are risk of developing neurodegeneration in females. Furthermore, aging-related genes in the hippocampus and frontal cortex appear to be more frequently involved in the pathogenesis of AD. It seems that the development of AD in particular sexes may be conditioned by a diverse molecular background.Scientific research into whether microorganisms can cause neurodegeneration goes back over thirty years. Many theories have been put forward as to how microorganisms can lead to the development of neurodegeneration, ranging from their ability to interfere with protein trafficking and cause protein aggregation, the activation of microglia towards a pro-inflammatory phenotype consistent with poorer clearance of cellular debris, and a number of other processes (Piekut et al., 2022;Dorszewska et al. 2023).In this issue, we also report on the potential involvement of microorganisms in the pathogenesis of PD and stroke. In PD, the bacterial microbiota is directly related to parameters that play a potential role in normal intestinal integrity, immunity, metabolism, and proper functioning of the gut-brain axis. We suggest that the gut microbiota may be used for early diagnosis of PD and potential targets for preventing or treating the symptoms of this disease. Furthermore, preserving intestinal homeostasis with probiotics may lead to a promising treatment strategy for PD. One from them, the SymproveTM probiotic, which significantly improves the parameters of both the intestines and the brain in the experimental PD model may be used in the prevention of PD in the future.At the same time, dysbiosis resulting from a change in the composition and function of the intestinal microflora may cause disturbances in the microbiota-gut-brain axis and be the beginning of stroke and closely associated with the development of stroke risk factors. Summing, further research on the participation of microorganisms in the development of diseases based on neuronal degeneration may contribute to improving the diagnosis and treatment of incurable neurological diseases.It seems that a better understanding of the molecular mechanisms associated with neurodegeneration may contribute to a better understanding of the causes of sudden neuronal death in specific areas of the central nervous system. Understanding the mechanism of neuronal damage may contribute to slowing down the progression or delaying the onset of degenerative neurological diseases and to improving the quality of life of people affected by a neurodegenerative disease.
No takes yet. Share an insight, caveat, or question.
Dorszewska et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: